Got it 👍. You’ve shared an image that lists the Introductory topics of Pharmacology.

I’ll
draft a long, detailed explanatory note for medical students, structured around those points,
referencing K.D. Tripathi – Essentials of Medical Pharmacology (latest/recent editions).

📖 Introduction to Pharmacology – Explanatory Note

1. Definitions & Branches

 Pharmacology: Derived from the Greek words pharmakon (drug) and logos (study),
it is the science of drugs including their origin, composition, pharmacokinetics,
pharmacodynamics, therapeutic uses, and toxicology.
 Drug: Any chemical substance that, when introduced into a living organism, modifies
one or more of its functions.
 Branches of Pharmacology (as per K.D. Tripathi):
o Pharmacodynamics – Study of biochemical and physiological effects of drugs
and their mechanisms of action (i.e., “what the drug does to the body”).
o Pharmacokinetics – Study of absorption, distribution, metabolism, and
excretion of drugs (i.e., “what the body does to the drug”).
o Pharmacotherapeutics – Application of drugs for prevention and treatment of
diseases.
o Chemotherapy – Use of drugs to inhibit or kill infective organisms or
malignant cells without harming the host.
o Toxicology – Study of poisonous effects of drugs and other chemicals.

o Clinical Pharmacology – Evaluation of drug effects in humans, including

clinical trials, drug interactions, and adverse effects.

2. Nature & Sources of Drugs

 Nature: Drugs can be synthetic, semi-synthetic, or natural. They may be solids,
liquids, or gases with varying chemical properties influencing their pharmacological
actions.
 Sources:
o Natural sources

 Plant origin: e.g., morphine (Papaver somniferum), atropine (Atropa

belladonna).
 Animal origin: e.g., insulin (pancreas of pigs/cattle), heparin (lung
tissue of cattle).
  Minerals: e.g., iron, magnesium sulfate.
 Microorganisms: e.g., penicillin, streptomycin.
o Synthetic & Semi-synthetic: e.g., barbiturates, amoxicillin.

o Biotechnological/Genetic engineering products: e.g., recombinant insulin,

monoclonal antibodies.

3. Dosage Forms and Routes of Drug Administration

 Dosage Forms: Tablet, capsule, syrup, suspension, injection, ointment, cream, patch,
inhaler, etc.
 Routes of Administration:
o Enteral: Oral, sublingual, rectal.

o Parenteral: Intravenous (IV), intramuscular (IM), subcutaneous (SC),

intradermal.
o Topical/Local: Skin, eye drops, ear drops, nasal sprays.

o Inhalational: Gaseous and volatile drugs.

 Choice of route depends on drug properties, urgency, patient’s condition, and desired
onset of action.

4. Terminology Used
 Agonist: A drug that activates a receptor to produce a biological response.
 Antagonist: A drug that blocks receptor activity.
 Potency: Amount of drug needed to produce a given effect.
 Efficacy: Maximal effect a drug can produce.
 Therapeutic index: Ratio between toxic dose and therapeutic dose, indicating drug
safety.
 Bioavailability: Fraction of unchanged drug reaching systemic circulation.

5. Classification, Abbreviations, Prescription, Drug Calculation, Weights & Measures

 Classification of Drugs:
o Based on therapeutic use (antihypertensives, antidiabetics).

o Based on mechanism of action (β-blockers, ACE inhibitors).

 o Based on chemical structure (sulfonamides, benzodiazepines).

 Common Abbreviations (used in prescriptions):

o OD (once daily), BD (twice daily), TDS (three times daily), HS (at bedtime),
SOS (as required).
 Prescription Writing: Should include patient details, date, drug name, strength,
dosage form, frequency, duration, and doctor’s signature. Legibility and avoidance of
dangerous abbreviations are emphasized.
 Drug Calculation: Important for pediatric, geriatric, and critical care patients. Based
on body weight, body surface area, and dose adjustment in renal/hepatic impairment.
 Weights and Measures:
o Metric system (gram, milligram, microgram).

o Volume (liter, milliliter).

o Accuracy is critical to avoid overdose or underdose.

📚 References

1. Tripathi, K.D. Essentials of Medical Pharmacology, 9th Edition, Jaypee Brothers

Medical Publishers, New Delhi, 2018 (latest available edition at present).
2. Katzung, B.G. Basic and Clinical Pharmacology, 16th Edition, McGraw-Hill, 2021.
3. Rang, H.P., Dale, M.M. Rang & Dale’s Pharmacology, 9th Edition, Elsevier, 2019.

Would you like me to expand this into a structured student handout/notes format (with
tables and bullet comparisons) so it’s easier for exam preparation, or keep it as a continuous
descriptive write-up?
Got it ✅
Here’s a long, explanatory note on Nature & Sources of Drugs, structured in detail and
aligned with Essentials of Medical Pharmacology by K. D. Tripathi (latest editions). This is
written in a way MBBS students can use directly for exam answers.

Nature and Sources of Drugs

1. Nature of Drugs
 Definition of a drug:
 o A chemical substance of known structure, other than a nutrient or essential
dietary ingredient, which produces a biological effect when administered to a
living organism.
o In practice, “drug” is any active chemical entity present in a medicine used for
diagnosis, prevention, treatment, or cure of disease.
 General Characteristics:
o Drugs are exogenous chemicals (i.e., not produced within the body), though
some endogenous substances are also used therapeutically (e.g., insulin,
thyroxine).
o Act by interacting with specific targets/receptors/enzymes/ion channels in
the body.
o Their therapeutic utility depends on selectivity, efficacy, and safety.

o Same substance can be drug or poison depending on dose (e.g., digoxin,

morphine).

2. Sources of Drugs
K. D. Tripathi classifies drugs based on their origin into natural, semi-synthetic, synthetic,
and biotechnological sources.
A. Natural Sources
1. Plant origin
o Alkaloids → e.g., morphine (opium poppy), atropine (belladonna).

o Glycosides → e.g., digoxin (digitalis leaf).

o Tannins, resins, gums also used.

o Essential oils → clove oil, eucalyptus oil.

2. Animal origin
o Hormones → insulin (pancreas of pigs/cattle, now recombinant).

o Enzymes → pepsin, hyaluronidase.

o Heparin (from pig intestine).

3. Microbial origin
o Antibiotics → penicillins (Penicillium), streptomycin (Streptomyces).

o Immunosuppressants → cyclosporine.

4. Mineral origin
 o Metals → iron, zinc, magnesium salts.

o Non-metals → iodine (thyroid disorders), fluoride (dental prophylaxis).

B. Semi-Synthetic Drugs
 Derived by chemical modification of natural compounds.
 Aim: improve efficacy, reduce toxicity, enhance pharmacokinetics.
 Examples:
o Ampicillin (from penicillin G).

o Semi-synthetic opioids (heroin, oxycodone).

o Cephalosporins (modified from cephalosporin C).

C. Synthetic Drugs
 Entirely prepared in laboratories by chemical synthesis.
 Represent the largest group in modern therapeutics.
 Examples:
o Sulfonamides (antimicrobials).

o Antihistamines (cetirizine, loratadine).

o Oral hypoglycemics (sulfonylureas, metformin).

o Proton pump inhibitors (omeprazole, pantoprazole).

D. Biotechnological / Genetic Engineering Sources

 Recombinant DNA technology and monoclonal antibody techniques provide a new
class of drugs.
 Examples:
o Recombinant human insulin, erythropoietin, growth hormone.

o Monoclonal antibodies → trastuzumab, rituximab.

o Interferons, vaccines produced via biotechnology.

E. Marine Sources (Newer Area)

  Marine flora and fauna are now being explored.
 Examples:
o Ziconotide (from cone snail venom, analgesic).

o Cytarabine (from sea sponge, anticancer).

3. Modern Perspective
 Earlier: Drugs were mostly crude natural extracts, efficacy uncertain.
 Now:
o Purified, structurally characterized, standardized.

o Rationally designed based on molecular targets (e.g., imatinib – tyrosine

kinase inhibitor).
o Safer, more effective agents available due to advances in medicinal chemistry
and pharmacogenomics.

4. Summary Table (Exam-Friendly)

Source Examples

Plant Morphine, Atropine, Digoxin, Quinine

Animal Insulin, Heparin, Pepsin

Microbial Penicillin, Streptomycin, Cyclosporine

Mineral Iron, Iodine, Fluoride

Semi-synthetic Ampicillin, Cephalosporins, Semi-synthetic opioids

Synthetic Sulfonamides, Antihistamines, Metformin

Biotechnological Recombinant insulin, Monoclonal antibodies, Interferons

Marine Cytarabine, Ziconotide

✅ This version matches the style and depth of K. D. Tripathi’s MBBS-level explanations.

Would you like me to also make a flowchart/mind map of sources of drugs so it’s easier to
revise quickly before exams?
Here’s a detailed explanatory note on Dosage Forms & Routes of Drug Administration
based on the style and content of K.D. Tripathi’s Essentials of Medical Pharmacology (latest
editions). This is structured for MBBS students—comprehensive yet exam-oriented.

Dosage Forms and Routes of Drug Administration

1. Dosage Forms
 Definition:
o A dosage form is the physical form in which a drug is produced and
administered to patients.
o Prepared to deliver a drug in an accurate dose, in a suitable form, to ensure
stability, palatability, and desired therapeutic effect.
 Purposes of dosage forms:
o Facilitate administration of drugs.

o Ensure accurate dose and uniformity.

o Protect drug from environmental factors (light, moisture, gastric pH).

o Modify drug release (immediate, delayed, sustained).

o Mask unpleasant taste or odor.

o Provide safe and convenient handling.

 Common dosage forms (as per KD Tripathi):

1. Solid Forms
 Tablets, capsules, powders, granules, lozenges.
 Advantages: accurate dosing, stability, portability.
 Disadvantages: slow onset (unless modified), difficulty in swallowing
for some patients.
2. Liquid Forms
 Solutions, suspensions, emulsions, syrups, elixirs.
 Useful for pediatrics/geriatrics, faster absorption.
 Require preservatives, less stable.
3. Semisolid Forms
 Ointments, creams, gels, pastes, suppositories.
 For topical, rectal, vaginal use.
 4. Gaseous Forms
 Inhalers, aerosols, vapors (O₂, anesthetic gases).
 Rapid systemic/local action via respiratory tract.

2. Routes of Drug Administration

 Definition:
o Path by which a drug is brought into contact with the body.

o Choice depends on:

 Desired speed of onset,

 Site of action,
 Drug properties,
 Patient condition.
 Broad Categories:
1. Enteral Routes (via alimentary canal)
 Oral
 Most common, safe, economical, convenient.
 Limitations: slow onset, first-pass metabolism, unsuitable for
unconscious/vomiting patients.
 Examples: tablets, capsules, syrups.
 Sublingual/Buccal
 Drug placed under tongue or in buccal pouch → absorbed
directly into systemic circulation.
 Bypasses first-pass metabolism.
 Example: Nitroglycerin, buprenorphine.
 Rectal
 Suppositories, enemas.
 Useful in vomiting, unconsciousness, children.
 Partial avoidance of first-pass metabolism.
 Disadvantage: irregular absorption.
2. Parenteral Routes (injection routes – bypass GIT)
  Intravenous (IV)
 Direct into bloodstream → rapid onset, 100% bioavailability.
 Used in emergencies, precise control of plasma levels.
 Risks: infection, thrombophlebitis, anaphylaxis, cannot be
recalled once injected.
 Intramuscular (IM)
 Into skeletal muscle → slower than IV but faster than oral.
 Suitable for oily/depot preparations.
 Site: deltoid, gluteus, vastus lateralis.
 Subcutaneous (SC)
 Beneath skin → slower absorption.
 Useful for insulin, vaccines.
 Limitation: painful, not suitable for irritant drugs.
 Intradermal
 Into skin dermis (small volume).
 Example: Mantoux test, BCG vaccine.
3. Topical Routes (local or systemic effects)
 Skin (ointments, creams, transdermal patches).
 Local action (antifungals, steroids).
 Systemic action via patches (nicotine, fentanyl, nitroglycerin).
 Eye, ear, nasal mucosa
 Local use (antibiotics, decongestants).
 Nasal route can provide systemic action (desmopressin,
calcitonin).
 Inhalation
 Gases, vapors, aerosols (O₂, anesthetic gases, salbutamol).
 Rapid action due to large alveolar surface area.
 Rectal/Vaginal local use
 Antifungal pessaries, rectal anti-hemorrhoidal agents.
3. Factors Influencing Choice of Route
 Desired speed of onset (e.g., IV for emergencies).
 Drug properties: stability in GIT, solubility, irritant potential.
 Patient condition: conscious/unconscious, age, compliance.
 Need to avoid first-pass metabolism (e.g., sublingual, rectal, parenteral).
 Duration of action: short-acting vs. sustained-release forms.

4. Summary Table (KD Tripathi style)

Route Advantages Disadvantages Examples

Slow onset, first-pass Paracetamol,

Oral Safe, convenient, economical
metabolism, GIT issues amoxicillin

Rapid, avoids first-pass Limited drugs, short

Sublingual/Buccal Nitroglycerin
metabolism duration

Useful in
Irregular absorption, Diazepam,
Rectal vomiting/unconscious, partial
irritation indomethacin
FPM avoidance

Rapid, 100% bioavailability, Risky, requires Dopamine,

IV
emergencies expertise, irreversible morphine

Moderate speed, depot Pain, nerve injury, Vaccines,

IM
possible limited volume antibiotics

Slow, suitable for self- Painful, unsuitable for

SC Insulin, heparin
administration irritants

Requires device, patient Salbutamol,

Inhalation Very rapid, local/systemic use
cooperation anesthetic gases

Slow, skin irritation,

Sustained systemic effect, Fentanyl patch,
Transdermal only potent lipophilic
avoids FPM nicotine patch
drugs

✅ This note integrates KD Tripathi’s standard explanations with exam-ready organization

(definitions, classifications, pros/cons, examples, table).
Would you like me to also prepare a flowchart diagram of routes of administration (enteral
vs parenteral vs topical) for quick visual recall?